Eric Benevich, Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 10,198 shares at $80.83 ($822K) on 2022-02-07, disclosed to the SEC on 2022-02-09.
Seasonal sale ($822k) by Chief Commercial Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.68 | 809 | $65K | 7.9% |
| 2 | $80.68 | 809 | $65K | 7.9% |
| 3 | $80.78 | 1,280 | $103K | 12.6% |
| 4 | $80.78 | 1,280 | $103K | 12.6% |
| 5 | $80.83 | 2,030 | $164K | 20.0% |
| 6 | $80.83 | 2,030 |
| $164K |
| 20.0% |
| 7 | $79.67 | 980 | $78K | 9.5% |
| 8 | $79.67 | 980 | $78K | 9.5% |
| Total | $80.57 avg | 10,198 | $822K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $503K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $369K | — | Filing → |